Therapy News and Research

RSS

New drug target could help prevent opioid tolerance and addiction

Researchers have identified a brain mechanism that could be a drug target to help prevent tolerance and addiction to opioid pain medication, such as morphine, according to a study by Georgia State University and Emory University.

23 Aug 2016

Injecting omega-3 fatty acid reduces brain damage in neonatal mouse model of stroke

Researchers from Columbia University Medical Center found that omega-3 fatty acids reduced brain damage in a neonatal mouse model of stroke.

23 Aug 2016

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy.

19 Aug 2016

$Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures$

Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures

Vertebroplasty is a safe and effective procedure to reduce acute pain and disability in patients who have experienced spinal fractures within a 6-week period, according to a new study published this week in The Lancet.

19 Aug 2016

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.

19 Aug 2016

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1).

19 Aug 2016

Smokers who switch to vaping may have fewer respiratory infections, study reveals

The majority of smokers who successfully switch to vaping say they have fewer respiratory infections, according to a study led by Queen Mary University of London.

19 Aug 2016

Added benefit of lung cancer drug not proven, says IQWiG

Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy.

19 Aug 2016

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

19 Aug 2016

Added benefit still not proven for epilepsy drug

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adults and adolescents from 16 years of age with epileptic seizures.

19 Aug 2016

Penn researchers uncover strategy to reverse effects of dyskeratosis congenita

Dyskeratosis congenita, or DC, is a rare, inherited disease for which there are limited treatment options and no cure.

18 Aug 2016

Cell therapy product can accelerate brain remyelination in mice

Demyelinating diseases, such as multiple sclerosis and leukodystrophy, are characterized by damage to the protective myelin sheath that surrounds the axons of neurons.

18 Aug 2016

Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Wearables have proliferated in the marketplace, but there's still a lot of opportunity for growth. One of the ways in which wearables are limited is that people expect their wearables to really measure what they feel is important to be measured

18 Aug 2016

Scientists find way to boost efficiency with which CRISPR-Cas9 cuts and disables genes

CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.

18 Aug 2016

Research findings open avenues for creating new classes of anticancer drugs

A new study at Los Alamos National Laboratory and in collaboration with Stanford Synchrotron Radiation Lightsource greatly improves scientists' understanding of the element actinium. The insights could support innovation in creating new classes of anticancer drugs.

18 Aug 2016

Scientists discover underlying mechanisms of proptosis in patients with thyroid eye disease

Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have identified new underlying mechanisms of proptosis, or bulging of the eyes, in patients with acute thyroid eye disease.

18 Aug 2016

Study finds 10% of patients admitted into hospitals colonised with dreaded pathogens

According to National Reference Center for Surveillance of Nosocomial Infections esti-mates, up to 15,000 patients die of hospital-acquired infections in Germany every year.

18 Aug 2016

Music interventions help improve quality of life in cancer patients

We've all heard of laughter being the best medicine, but what about music? A systematic review published by the Cochrane Library found that there is significant evidence that music interventions help alleviate symptoms of anxiety, pain and fatigue in cancer patients, while also boosting their quality of life.

17 Aug 2016

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry.

17 Aug 2016

Digital risk calculator provides faster, reliable estimation of GIST recurrence

GIST (Gastrointestinal Stromal Tumor) is an uncommon type of sarcoma found in the tissues supporting the digestive system (stomach and intestines).

17 Aug 2016

Therapy News and Research

New drug target could help prevent opioid tolerance and addiction

Injecting omega-3 fatty acid reduces brain damage in neonatal mouse model of stroke

Genekam develops first therapeutic molecule candidate for Zika viruses

Vertebroplasty helps decrease acute pain in patients with osteoporotic fractures

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of combination drug for HIV-infected patients not proven

Smokers who switch to vaping may have fewer respiratory infections, study reveals

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Added benefit still not proven for epilepsy drug

Penn researchers uncover strategy to reverse effects of dyskeratosis congenita

Cell therapy product can accelerate brain remyelination in mice

Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Scientists find way to boost efficiency with which CRISPR-Cas9 cuts and disables genes

Research findings open avenues for creating new classes of anticancer drugs

Scientists discover underlying mechanisms of proptosis in patients with thyroid eye disease

Study finds 10% of patients admitted into hospitals colonised with dreaded pathogens

Music interventions help improve quality of life in cancer patients

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Digital risk calculator provides faster, reliable estimation of GIST recurrence

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News